Close window

chemagen is now part of Revvity
Visit to see our full portfolio

Close window

Nucleic acids from MRSA and GBS application note

Automated nucleic acid extraction from MRSA and GBS

Optimized Pathogen Detection: A Compatibility Evaluation of Revvity chemagic™ 360 system and NZYTech qPCR Kits for MRSA and GBS detection

Automated nucleic acid extraction systems are essential in molecular diagnostic labs for efficient, reliable, and timely results. They reduce hands-on time, ensure consistency, and enable high-throughput processing of multiple samples simultaneously. Group B Streptococcus (GBS) and Methicillin-resistant Staphylococcus aureus (MRSA) are significant bacterial pathogens linked to healthcare-associated infections (HAIs) in vulnerable populations such as newborns, pregnant women, and hospitalized patients. Swift and precise detection of these pathogens is crucial for effective treatment and the prevention of HAIs, underscoring the importance of robust diagnostic methods in healthcare settings.

In this application note, we present the compatibility of the chemagic 360-D instrument and the chemagic™ Pathogen NA gDNA Kit H96 (IVD-1049) with the NZYTech qPCR Kits for MRSA and GBS detection.

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.